Selection of cross-resistance following exposure of Pseudomonas aeruginosa clinical isolates to ciprofloxacin or cefepime

Samer A. Alyaseen; Kerryl E. Piper; Mark S. Rouse; James M. Steckelberg; Robin Patel

doi:10.1128/AAC.49.6.2543-2545.2005

Selection of cross-resistance following exposure of Pseudomonas aeruginosa clinical isolates to ciprofloxacin or cefepime

Samer A. Alyaseen, Kerryl E. Piper, Mark S. Rouse, James M. Steckelberg, Robin Patel

Laboratory Medicine and Pathology

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

Exposure of ciprofloxacin- and cefepime-susceptible Pseudomonas aeruginosa isolates to increasing concentrations of ciprofloxacin selected for ciprofloxacin resistance in 26/27 and cefepime nonsusceptibility in 7/27 isolates. Exposure of the isolates to increasing concentrations of cefepime selected for cefepime nonsusceptibility in 20/27 isolates but not for ciprofloxacin resistance.

Original language	English (US)
Pages (from-to)	2543-2545
Number of pages	3
Journal	Antimicrobial Agents and Chemotherapy
Volume	49
Issue number	6
DOIs	https://doi.org/10.1128/AAC.49.6.2543-2545.2005
State	Published - Jun 2005

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)
Infectious Diseases

Access to Document

10.1128/AAC.49.6.2543-2545.2005

Cite this

@article{bd402015a47544a883769126ee23252e,

title = "Selection of cross-resistance following exposure of Pseudomonas aeruginosa clinical isolates to ciprofloxacin or cefepime",

abstract = "Exposure of ciprofloxacin- and cefepime-susceptible Pseudomonas aeruginosa isolates to increasing concentrations of ciprofloxacin selected for ciprofloxacin resistance in 26/27 and cefepime nonsusceptibility in 7/27 isolates. Exposure of the isolates to increasing concentrations of cefepime selected for cefepime nonsusceptibility in 20/27 isolates but not for ciprofloxacin resistance.",

author = "Alyaseen, {Samer A.} and Piper, {Kerryl E.} and Rouse, {Mark S.} and Steckelberg, {James M.} and Robin Patel",

year = "2005",

month = jun,

doi = "10.1128/AAC.49.6.2543-2545.2005",

language = "English (US)",

volume = "49",

pages = "2543--2545",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "6",

}

TY - JOUR

T1 - Selection of cross-resistance following exposure of Pseudomonas aeruginosa clinical isolates to ciprofloxacin or cefepime

AU - Alyaseen, Samer A.

AU - Piper, Kerryl E.

AU - Rouse, Mark S.

AU - Steckelberg, James M.

AU - Patel, Robin

PY - 2005/6

Y1 - 2005/6

N2 - Exposure of ciprofloxacin- and cefepime-susceptible Pseudomonas aeruginosa isolates to increasing concentrations of ciprofloxacin selected for ciprofloxacin resistance in 26/27 and cefepime nonsusceptibility in 7/27 isolates. Exposure of the isolates to increasing concentrations of cefepime selected for cefepime nonsusceptibility in 20/27 isolates but not for ciprofloxacin resistance.

AB - Exposure of ciprofloxacin- and cefepime-susceptible Pseudomonas aeruginosa isolates to increasing concentrations of ciprofloxacin selected for ciprofloxacin resistance in 26/27 and cefepime nonsusceptibility in 7/27 isolates. Exposure of the isolates to increasing concentrations of cefepime selected for cefepime nonsusceptibility in 20/27 isolates but not for ciprofloxacin resistance.

UR - http://www.scopus.com/inward/record.url?scp=19544371747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19544371747&partnerID=8YFLogxK

U2 - 10.1128/AAC.49.6.2543-2545.2005

DO - 10.1128/AAC.49.6.2543-2545.2005

M3 - Article

C2 - 15917569

AN - SCOPUS:19544371747

SN - 0066-4804

VL - 49

SP - 2543

EP - 2545

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

IS - 6

ER -

Selection of cross-resistance following exposure of Pseudomonas aeruginosa clinical isolates to ciprofloxacin or cefepime

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this